Table 1.
Anti-TB Drug | Retrieved Articles | ||||||||
---|---|---|---|---|---|---|---|---|---|
Data on Plasma Concentration | Data on Milk Concentration | Data on Plasma Concentration in Breastfed Infant | |||||||
A | B | C | A | B | C | A | B | C | |
PK studies, including population kinetics | |||||||||
Bedaquiline | 7 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Clofazimine | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Cycloserine /Terizidone |
17 | 9 | 5 | 0 indirect information, no access to the original publication |
0 indirect information, no access to the original publication |
0 indirect information, no access to the original publication |
0 | 0 | 0 |
Levofloxacin | 31 | 12 | 6 | 2 | 1 | 1 | 6 | 0 | 0 |
Linezolid | 53 | 7 | 3 | 6 | 3 | 3 | 11 | 3 | 3 |
Pretomanid | 14 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Pyrazinamide | 110 | 7 | 5 | 3 | 2 | 0 | 19 | 0 | 0 |
Streptomycin | 332 1 | 5 | 2 | 2 (Japanese language, Russian language) | 8 | 0 | 0 | ||
PK studies, modelling approaches | |||||||||
Ethambutol | 2 2 | 0 | 0 | 1 | 1 | 1 | 6 | 1 3 | n.a. |
INH | 22 2 | 2 | 0 | No new data after 2017 | 9 | 1 4 | n.a. | ||
Rifampicin | 141 2 | 3 | 0 | 7 | 1 | 1 | 14 | 1 3 | n.a. |